These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2357784)

  • 41. Side-effects of spironolactone therapy in the hirsute woman.
    Helfer EL; Miller JL; Rose LI
    J Clin Endocrinol Metab; 1988 Jan; 66(1):208-11. PubMed ID: 3335604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission.
    Carmina E; Lobo RA
    Fertil Steril; 1998 Jun; 69(6):1075-9. PubMed ID: 9627295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged suppression of hirsutism with combination therapy in an adolescent with insulin resistance and acanthosis nigricans.
    Moore DC
    J Adolesc Health Care; 1987 Sep; 8(5):445-8. PubMed ID: 3667400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of hirsutism.
    Falsetti L; Gambera A; Platto C; Legrenzi L
    Am J Clin Dermatol; 2000; 1(2):89-99. PubMed ID: 11702316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components.
    Rangnekar KN; Rao SS; Joshi UM
    Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of effect of spironolactone on hair shaft diameter in hirsute females.
    McLellan AR; Rentoul J; MacKie R; McInnes GT
    Postgrad Med J; 1989 Jul; 65(765):459-62. PubMed ID: 2690044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
    Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of ovulation with spironolactone (Aldactone) in anovulatory oligomenorrheic and hyperandrogenic women.
    Evron S; Shapiro G; Diamant YZ
    Fertil Steril; 1981 Oct; 36(4):468-71. PubMed ID: 6793406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D; Smith S; Zacur H
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medical Treatment of Hirsutism in Women.
    Lumachi F; Basso SM
    Curr Med Chem; 2010; 17(23):2530-8. PubMed ID: 20491644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL; Roy S; Lobo RA
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.
    Dodin S; Faure N; Cédrin I; Méchain C; Turcot-Lemay L; Guy J; Lemay A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):575-82. PubMed ID: 8548942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New therapeutic approach to the hirsute patient.
    Boisselle A; Tremblay RR
    Fertil Steril; 1979 Sep; 32(3):276-9. PubMed ID: 488407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
    Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.